XENE - Xenon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XENE is currently covered by 13 analysts with an average price target of $45.86. This is a potential upside of $15.57 (51.4%) from yesterday's end of day stock price of $30.29.

Xenon Pharmaceuticals's activity chart (see below) currently has 58 price targets and 92 ratings on display. The stock rating distribution of XENE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.44% with an average time for these price targets to be met of 421.05 days.

Highest price target for XENE is $67, Lowest price target is $46, average price target is $55.77.

Most recent stock forecast was given by MOHIT BANSAL from WELLS FARGO on 13-May-2025. First documented stock forecast 01-Dec-2014.

Currently out of the existing stock ratings of XENE, 38 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$47

$16.71 (55.17%)

$55

5 days ago
(13-May-2025)

1/3 (33.33%)

$17.4 (58.78%)

438

Buy

$53

$22.71 (74.98%)

$53

5 days ago
(13-May-2025)

0/4 (0%)

$23.4 (79.05%)

Buy

$55

$24.71 (81.58%)

$60

5 days ago
(13-May-2025)

8/14 (57.14%)

$25.4 (85.81%)

450

Buy

$55

$24.71 (81.58%)

$56

5 days ago
(13-May-2025)

5/15 (33.33%)

$25.4 (85.81%)

492

Buy

$67

$36.71 (121.20%)

$60

3 months 7 days ago
(11-Feb-2025)

0/3 (0%)

$28.61 (74.52%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?

On average it took 421.05 days on average for the stock forecasts to be realized with a an average price target met ratio 47.44

Which analyst has the current highest performing score on XENE (Xenon Pharmaceuticals) with a proven track record?

ANDREW TSAI

Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?

Andrew Tsai works at JEFFERIES and has 3 price targets and 3 ratings on XENE

Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?

David Hoang with highest potential upside - $36.71

Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?

Maury Raycroft with lowest potential downside - -$10.24

Xenon Pharmaceuticals in the News

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to four new non-officer employees consisting of an aggregate of 78,600 share options and 1,800 performance share units...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?